Delivery Order SPE2DR25D1053-SPE2DR26FT760
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,096.83 to AmerisourceBergen Drug Corp for 30 tablets of ADDYI 100 mg on September 18, 2025, with completion scheduled for September 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,410.28 to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15,454.99 on September 16, 2025, for the supply of ADDYI 100 mg tablets in packages of 30. This non-set-aside, competitively awarded delivery order carries a firm fixed price structure and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as one of the nation's...
- The Defense Logistics Agency awarded a delivery order valued at $2,759.58 to AmerisourceBergen Drug Corp for the supply of ADDYI 100 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract was executed on July 10, 2025, with an ultimate completion date of July 11, 2025, and utilizes firm fixed pricing. The awardee, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $35,858.57 to AmerisourceBergen Drug Corp for supply of ADDYI 100 mg tablets in quantities of 30-count units. The contract is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and was awarded on September 25, 2025, with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of ADDYI 100 mg tablets in quantities of 30 tablets per unit, with a ceiling value of $31,068.83. This competitive award utilizes firm fixed pricing and is structured as a delivery order without set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion...
- The Defense Logistics Agency awarded a $1,935.74 delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) under a firm fixed price contract type. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This contract represents a non-set-aside, competitively awarded delivery order, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency has awarded a delivery order valued at $4,889.15 to AmerisourceBergen Drug Corp for the supply of ADDYI 100 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of June 2, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $11.3K to AmerisourceBergen Drug Corp for 30-count tablets of ADDYI 100 mg on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing supply of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets in a quantity of 30 units, with a ceiling value of $11,432.00. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of October 8, 2025. The award was issued on October 7, 2025, with performance to be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT760Delivery Order
The Defense Logistics Agency awarded a competitive delivery order valued at $1,957.14 to AmerisourceBergen Drug Corp for the supply of ADDYI 100 mg tablets in quantities of 30 units. The order, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The underlying contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/10/25 |